Lieberman Gerald M's Form 4 filing
Entera Bio Ltd. (ENTX) · filed Dec 27, 2023
- Accession no.
- 0001178913-23-003988
- Filed
- Dec 27, 2023, 5:00 PM ET
- Trade date
- Dec 22, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $17.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lieberman Gerald MCIK 0001234346 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +23,952 | $0.71 | +$17,005.92 | 226,961 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | Ordinary Shares, par value NIS 0.0000769 per share | PPurchaseAcquired | +23,952 | $0.125 | +$2,994 | 23,952 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.